A ,4lactone isolated from Fusarium sp. has been shown to be a potent specific inhibitor of the enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) synthase 
The fungal metabolites lovastatin and compactin are specific competitive inhibitors of the enzyme 3-hydroxy-3-rnethylglutaryl coenzyme A (HMG-CoA) reductase (1) (2) (3) . Administration of these compounds to cultured animal cells (4) , to intact animals in vivo (1, 5) , and to humans (6, 7) resulted in an overall decrease in the synthesis of cholesterol. Thus, inhibition of a specific enzyme in the cholesterol biosynthetic pathway (HMG-CoA reductase) was directly correlated with the activity of the overall pathway in a number of different biological systems.
A number of studies also have suggested that HMG-CoA synthase [(S)-3-hydroxy-3-methylglutaryl-CoA acetoacetylCoA-lyase (CoA-acetylating), EC, 4.1.3.5], the first committed step in isoprenoid biosynthesis, may be an important site of control for the cholesterol pathway. The activity of this enzyme is affected by agents that alter cholesterol synthesis in the livers of chickens (8) and rats (8) (9) (10) . Studies in Chinese hamster ovary cells (11, 12) , HeLa (13), C-6 glia cells (14, 15) , and L-M cells (16) have also demonstrated that cholesterol biosynthesis was sensitive to changes in the HMG-CoA synthase activity.
With this in mind, and with the experience of finding inhibitors of HMG-CoA reductase, an effort was undertaken to discover agents that have a specific inhibitory effect on HMG-CoA synthase. This search led to the discovery that L-659,699 {(E,E)-11-[3-(hydroxymethyl)-4-oxo-2-oxytanyl]-3,5,7-trimethyl-2,4-undecadienenoic acid}, a P-lactone iso- (9) . Cytoplasmic HMG-CoA synthase was purified through the DEAE-cellulose step essentially as described by Mehrabian et al. (19) . This procedure was modified slightly by carrying out the 30-50% ammoniumi sulfate precipitation of the enzyme and by dialysis prior to the DEAE-cellulose step. As described by Mehrabian Other Enzymes. Mitochondrial HMG-CoA synthase was prepared through the DEAE-cellulose procedure and assayed by the method of Reed et al. (21) . HMG-CoA reductase was prepared and assayed by the method of Alberts et al. (1), fatty acid synthase was prepared by the method of Alberts et al. (22) , and acetoacetyl-CoA synthetase was prepared as described by Bergstrom et al. (9) .
Tissue Culture. Human Hep G2 cells obtained from Barbara Knowles (Wistar Institute, Philadelphia) were grown in 25-cm2 flasks in the presence of minimal essential medium and 10% fetal calf serum. Forty-eight hours before the experiment, the cells were switched to serum-free Higuchi medium (23 5 ,u/ml. After 3 hr, the reaction was stopped by aspiration of the medium and rinsing the cells three times with 3 ml of saline. The cells were treated for 30 min with 2 ml of 1 M NaOH and then this mixture was transferred to screw cap tubes and heated at 95°C for 1 hr. A portion (0.2 ml) was removed for protein determination by a microbiuret method (24) , the remainder of the solution was acidified with 0.2 ml of concentrated HCI and extracted three times with 4 ml each of petroleum ether. The petroleum ether extracts were combined, evaporated to dryness under nitrogen, and redissolved in 0.2 ml of ethyl acetate. A 0.1-ml aliquot was chromatographed on silica gel G thin-layer plates, which were developed in petroleum ether/diethyl ether/acetic acid (75:25:1). The plates were stained with iodine and those areas corresponding to standard cholesterol, oleic acid, and squalene were scraped into scintillation vials; 10 ml of Aquasol 2 was added and the radioactivity was determined.
Inhibition of Cholesterol Synthesis in Rats. Studies on the incorporation of [1-14C] acetate into plasma cholesterol were carried out as described (1) .
RESULTS
The 43-lactone L-659,699 inhibited HMG-CoA synthase with an IC50 of 0.12 ,uM, and a semilogarithmic plot of the activity of the enzyme versus inhibitor concentration is shown in Fig.   2 .
The inhibition of HMG-CoA synthase by L-659,699 was demonstrated to be reversible in the experiment described in Fig. 3 . In this study, the enzyme was preincubated in the absence and the presence of enough L-659,699 (0.4 ,uM) to produce almost complete inhibition of the synthase. When the same concentration of 0.4 AM was maintained in the assay system following the 5Cmin preincubation with the inhibitor, the enzyme was inhibited -80o. However, when The effect of L-659,699 on sterol biosynthesis from acetate and mevalonate was examined in Hep G2 cells, and the results are described in Table 3 . At a concentration 30 uM, L-659,699 inhibited acetate incorporation into cholesterol by of inhibition by L-659,699 of acetate and mevalonate into squalene was also examined and the results were similar to those observed for acetate and mevalonate incorporation into cholesterol in the Hep G2 cells. This study provides direct evidence that a block of HMG-CoA synthase activity will lead to a block in overall cholesterol biosynthesis. That a block in HMG-CoA synthase resulted in inhibition of sterol synthesis was first demonstrated by Schnitzer-Polokoff et al. (12) with a mutant Chinese hamster ovary cell defective in HMG-CoA synthase.
Incubation of L-659,699 with the Hep G2 cells not only inhibited cholesterol biosynthesis from acetate (synthesis was inhibited >90% at a concentration of 15.5 ,uM) but also appeared to induce the activity of HMG-CoA reductase in a dose-dependent manner (Table 4 ). The effects of L-659,699 on the activity of HMG-CoA synthase and ketothiolase were not measured in this experiment. (23), L-659,699 was added to the culture flasks at the indicated concentrations for 24 hr. At the end of the incubations, the cells were rinsed with 50 mM Tris-HCI/0.15 M NaCl, pH 7.4, scraped, suspended in a small volume of the same buffer, and stored at -80'C. After thawing, HMG-CoA reductase was solubilized and assayed by the method of Brown et al. (25) .
The effect ofL-659,699 on cholesterol biosynthesis in animals was also examined. The compound was administered orally to rats followed 1 hr later by an i.p. administration of [1- 14C]acetate. After 50 min more, the animals were bled and the incorporation of radioactivity into plasma cholesterol was determined. At a dose of 25 mg/kg, L-659,699 inhibited the incorporation of acetate into plasma sterols by 45% (data not shown).
DISCUSSION
The fl-lactone L-659,699 has been shown to be a potent inhibitor of the enzyme HMG-CoA synthase with an IC50 of 0.12 ,uM. Inhibition of the synthase by this compound was specific inasmuch as the enzymes HMG-CoA reductase, ,8-ketoacyl-CoA thiolase, acetoacetyl-CoA synthetase, and fatty acid synthase were not affected by the compound at concentrations up to 0.35 mM. The specificity was particularly interesting from a mechanistic point of view, since several reports have indicated that the mechanisms of the fatty acid synthase (26) and the 8-ketoacyl-CoA thiolase (27) involve acyl-S-enzyme intermediates, as does HMG-CoA synthase (28, 29) . Furthermore, while it has not been firmly established, it is likely that the mechanisms of HMG-CoA reductase and acetoacetyl-CoA synthetase also involve thiol intermediates. Yet, in spite of the presence of a reactive ,3-lactone moiety, L-659,699 had virtually no effect on any of these enzymes except HMG-CoA synthase. The reversibility of the inhibition is also informative, since it suggests that the mechanism of inhibition by L-659,699 is not via alkylation of the enzyme to form a stable alkyl-S-enzyme adduct, which might have been a consideration given the known pattern of reactivity of simple lactones toward nucleophiles to form stable alkylation products. Preliminary studies also suggest that the inhibition may be competitive with acetyl-CoA and possibly with acetoacetyl-CoA as well. However, these results are complicated by the fact that one of the substrates of HMG-CoA synthase, acetoacetyl-CoA, can act as an inhibitor (data not reported). Our finding of substrate inhibition was in agreement with the studies of Lowe and Tubbs (30) , who showed that the mitochondrial HMG-CoA synthase was inhibited by acetoacetyl-CoA.
An especially interesting aspect of these studies with L-659,699 concerns what they have already revealed about the regulation of the early steps of cholesterol biosynthesis. Inhibition of HMG-CoA reductase by lovastatin concomitantly induced HMG-CoA reductase, HMG-CoA synthase, and acetoacetyl-CoA synthetase in rat livers (9) , and HMGCoA synthase and reductase in cultured cells (12) . Similarly, we have observed that L-659,699 induced the activity of HMG-CoA reductase, an enzyme that is not the primary site of inhibition of the compound. HMG-CoA synthase activity, and that of 8-ketothiolase were not assayed in this experiment. However, this study suggests that a common feature in the regulation of these early enzymes of cholesterol biosynthesis may exist and that inhibition of any of the early enzymes will lead to changes in the levels of adjacent enzymes in the pathway.
Although the mechanism of inhibition of HMG-CoA synthase by L-659,699 cannot be deduced by a comparison of the activities of the analogs, it is obvious that the lactone ring must be intact for activity. The carboxyl end can be tampered with without much loss of activity; however, the inhibition is sensitive to changes in the 3-hydroxyl position.
Only two other naturally occurring f8-lactones with any important biological activity have been isolated. These are ebelactone, an inhibitor of pig liver esterase, pig pancreas lipase, and N-formyl-methionine aminopeptidase (31); and esterastin, which inhibited lysosomal acid lipase (32) .
We would like to thank Mrs. Joan Kiliyanski for typing this manuscript.
